Ureaplasma Species and Hyperammonemia in Neonates

Overview

About this study

This study will compare plasma ammonia levels among neonates with and without Ureaplasma colonization of their respiratory tract. It will compare neonates with and without Ureaplasma colonization to identify differences in clinical characteristics, including gestational age, mode of delivery, comorbidities, and clinical status. It will also compare neonates with and without hyperammonemia to identify differences in clinical characteristics, including gestational age, mode of delivery, comorbidities, and clinical status.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Neonates within the first 72 hours of life admitted to the NICU or ISCN.

Exclusion Criteria: 

  • Neonates older than 72 hours.
  • Neonates admitted to the Newborn Nursery (Level I nursery) at Rochester Methodist Hospital.
  • Neonates with a metabolic disorder known to cause hyperammonemia.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Robin Patel, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions